Literature DB >> 27914746

A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.

Gary P Wormser1, Franc Strle2, Eugene D Shapiro3, Raymond J Dattwyler4, Paul G Auwaerter5.   

Abstract

In older studies, a chronic distal symmetric sensory neuropathy was reported as a relatively common manifestation of late Lyme disease in the United States. However, the original papers describing this entity had notable inconsistencies and certain inexplicable findings, such as reports that this condition developed in patients despite prior antibiotic treatment known to be highly effective for other manifestations of Lyme disease. More recent literature suggests that this entity is seen rarely, if at all. A chronic distal symmetric sensory neuropathy as a manifestation of late Lyme disease in North America should be regarded as controversial and in need of rigorous validation studies before acceptance as a documented clinical entity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Borrelia burgdorferi; Lyme disease; Neuroborreliosis; Neuropathy; Peripheral neuropathy

Mesh:

Year:  2016        PMID: 27914746      PMCID: PMC5924701          DOI: 10.1016/j.diagmicrobio.2016.11.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  45 in total

1.  Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States.

Authors:  E Hilton; J DeVoti; J L Benach; M L Halluska; D J White; H Paxton; J S Dumler
Journal:  Am J Med       Date:  1999-04       Impact factor: 4.965

2.  Peripheral neuropathy in acrodermatitis chronica atrophicans (Herxheimer).

Authors:  H C Hopf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-05       Impact factor: 10.154

3.  Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features.

Authors:  W Kristoferitsch; E Sluga; M Graf; H Partsch; R Neumann; G Stanek; H Budka
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

Review 4.  Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.

Authors:  Takashi Kanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-13       Impact factor: 10.154

Review 5.  Nervous system Lyme disease.

Authors:  John J Halperin
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

6.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

Review 7.  Lyme borreliosis.

Authors:  Gerold Stanek; Gary P Wormser; Jeremy Gray; Franc Strle
Journal:  Lancet       Date:  2011-09-06       Impact factor: 79.321

8.  Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Authors:  Gary P Wormser; Martin Schriefer; Maria E Aguero-Rosenfeld; Andrew Levin; Allen C Steere; Robert B Nadelman; John Nowakowski; Adriana Marques; Barbara J B Johnson; J Stephen Dumler
Journal:  Diagn Microbiol Infect Dis       Date:  2012-10-11       Impact factor: 2.803

9.  Lyme disease testing by large commercial laboratories in the United States.

Authors:  Alison F Hinckley; Neeta P Connally; James I Meek; Barbara J Johnson; Melissa M Kemperman; Katherine A Feldman; Jennifer L White; Paul S Mead
Journal:  Clin Infect Dis       Date:  2014-05-30       Impact factor: 9.079

10.  Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E D Shapiro; E Logigian; A L Belman; L Dotevall; G P Wormser; L Krupp; G Gronseth; C T Bever
Journal:  Neurology       Date:  2007-05-23       Impact factor: 9.910

View more
  2 in total

Review 1.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

Review 2.  Comparison of Lyme Disease in the United States and Europe.

Authors:  Adriana R Marques; Franc Strle; Gary P Wormser
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.